Contrast Enhanced Harmonic Endoscopic Ultrasound (CH-EUS), Elastography, and Fractal Analysis in Predicting Pancreatic Cancer Aggressiveness and Response to Therapy. (CH-E-EUS)
Sponsor: Istituto Clinico Humanitas
A observational or N/A phase clinical study on Pancreatic Mass, this trial is ongoing. The trial is conducted by Istituto Clinico Humanitas and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Feb 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2022 — Jul 2024 [monthly]
Recruiting
First recorded
Oct 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Istituto Clinico Humanitas
For direct contact, visit the study record on ClinicalTrials.gov .